Cardiovascular Systems Inc - ESG Rating & Company Profile powered by AI
This webpage displays a free E,S&G report for Cardiovascular Systems Inc. This Sustainability score for Cardiovascular Systems Inc represents the company's reporting of the United Nations Sustainable Development Goals. This report of Cardiovascular Systems Inc leverages data from across the internet and also from public filings by Cardiovascular Systems Inc.
Cardiovascular Systems Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 7.0; made up of an environmental score of 6.4, social score of 6.7 and governance score of 8.0.
7.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
61 | Urban AG Corp | 7.1 | High |
61 | Yamashita Health Care Holdings Inc | 7.1 | High |
74 | Cardiovascular Systems Inc | 7.0 | High |
74 | EssilorLuxottica SA | 7.0 | High |
74 | Steris plc | 7.0 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Cardiovascular Systems Inc have an accelerator or VC vehicle to help deliver innovation?
Does Cardiovascular Systems Inc disclose current and historical energy intensity?
Does Cardiovascular Systems Inc report the average age of the workforce?
Does Cardiovascular Systems Inc reference operational or capital allocation in relation to climate change?
Does Cardiovascular Systems Inc disclose its ethnicity pay gap?
Does Cardiovascular Systems Inc disclose cybersecurity risks?
Does Cardiovascular Systems Inc offer flexible work?
Does Cardiovascular Systems Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Cardiovascular Systems Inc disclose the number of employees in R&D functions?
Does Cardiovascular Systems Inc conduct supply chain audits?
Does Cardiovascular Systems Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Cardiovascular Systems Inc conduct 360 degree staff reviews?
Does Cardiovascular Systems Inc disclose the individual responsible for D&I?
Does Cardiovascular Systems Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Cardiovascular Systems Inc disclose current and / or historical scope 2 emissions?
Does Cardiovascular Systems Inc disclose water use targets?
Does Cardiovascular Systems Inc have careers partnerships with academic institutions?
Did Cardiovascular Systems Inc have a product recall in the last two years?
Does Cardiovascular Systems Inc disclose incidents of discrimination?
Does Cardiovascular Systems Inc allow for Work Councils/Collective Agreements to be formed?
Has Cardiovascular Systems Inc issued a profit warning in the past 24 months?
Does Cardiovascular Systems Inc disclose parental leave metrics?
Does Cardiovascular Systems Inc disclose climate scenario or pathway analysis?
Does Cardiovascular Systems Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Cardiovascular Systems Inc disclose the pay ratio of women to men?
Does Cardiovascular Systems Inc support suppliers with sustainability related research and development?
Does Cardiovascular Systems Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Cardiovascular Systems Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Cardiovascular Systems Inc involved in embryonic stem cell research?
Does Cardiovascular Systems Inc disclose GHG and Air Emissions intensity?
Does Cardiovascular Systems Inc disclose its waste policy?
Does Cardiovascular Systems Inc report according to TCFD requirements?
Does Cardiovascular Systems Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Cardiovascular Systems Inc disclose energy use targets?
Does Cardiovascular Systems Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Cardiovascular Systems Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Cardiovascular Systems Inc
These potential risks are based on the size, segment and geographies of the company.
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.